http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2009116247-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L12-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-1613 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02B1-043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-453 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0051 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate | 2007-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2010-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2009116247-A |
titleOfInvention | METHODS AND OPHTHALMIC DEVICES APPLIED FOR TREATMENT OF EYE ALLERGY |
abstract | 1. An ophthalmic device containing approximately the minimum effective amount of an antiallergic agent. ! 2. The ophthalmic device of claim 1, wherein antiallergic agent is selected from the group consisting of atsetmetatsina, acrivastine, aldosterone, antazoline, astemizole, azatadine, azelastine, beclometasone, betamethasone, bromfenac, buklizina, carprofen, cetirizine, hlorpirilina, chlorpheniramine, clemastine, cromolyn, cyclizine, cyproheptadine, dexamethasone, diazolin, diclofenac, diphenhydramine, ebastine, emedastine, epinastine, etodolac, fenbufen, phenoprofen, fexofenadine, fludrocortisone, flurbiprofen, flurometalone, hydrometalone sysine, ibuprofen, indomethacin, ketoprofen, ketorolac tromethamine, ketotifen, levocabastine, levoceterisin, lodoxamide, loratadine, loteprednol, loxoprofen, medrizone, mepivacaine, napinofinolamine, naporinofinolamine, naporodinofinolamine, napirinofinolamine, napirinofinolamine, napirinofinolamine, napirinofinolamine, napirinofinolamine, napirinofinolone , phenylephrine, oxatamide, oxymetazoline, pemirolast, feniramin, picumast, prednisilone, promethazine, rimexalon, repirinast, sulindac, suprofen, tetrahydrozoline, terfenadine, thiaprofenic acid, t We note, tranilast, triamcinolone, trimeprazine, triprolidine, and pharmaceutically acceptable salts and mixtures thereof. ! 3. The ophthalmic device according to claim 1, where the antiallergic agent is selected from the group consisting of acrivastine, antazoline, astemizole, azatadine, azelastine, buclizine, cetirizine, clemastine, cromolyn, cyclizine, cyproheptadine, ebastine, emedastine, epinastisin, epinastin, epinastis, epinastis, epinastis, |
priorityDate | 2006-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 172.